Inhibitor

Bibliography

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Inhibitor Report for: CBD-carbamate-C16

cannabidiol (CBD), a non-psychoactive component of cannabis


General
Type Carbamate, Cannabinoid-Receptor-ligand
Chemical_Nomenclature 6-Hydroxy-50-methyl-4-pentyl-2'-(prop-1-en-2-yl)-10,20,30,40-tetrahydro-[1,10-biphenyl]-2-yl (4-chlorobenzyl) (methyl)carbamate
Canonical SMILES C1(=C(C=C(C=C1OC(=O)N(CC2=CC=C(C=C2)Cl)C)CCCCC)O[H])C3C(C(C)=C)CCC(=C3)C
InChI InChI=1S/C30H38ClNO3/c1-6-7-8-9-23-17-27(33)29(26-16-21(4)10-15-25(26)20(2)3)28(18-23)35-30(34)32(5)19-22-11-13-24(31)14-12-22/h11-14,16-18,25-26,33H,2,6-10,15,19H2,1,3-5H3
InChIKey OHHCIRJUIDNYFH-UHFFFAOYSA-N
Other name(s)
________________________________________________________________________________________________
MW|496.08
Formula|C30H38ClNO3
CAS_number|
PubChem|
UniChem|OHHCIRJUIDNYFH-UHFFFAOYSA-N
IUPHAR|
Wikipedia|

Target
Families | CBD-carbamate-C16 ligand of proteins in family: BCHE
Protein | human-BCHE

References:
Search PubMed for references concerning: CBD-carbamate-C16
    Title: Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease
    Jiang X, Zhang Z, Zuo J, Wu C, Zha L, Xu Y, Wang S, Shi J, Liu XH and Tang W <1 more author(s)>
    Ref: Eur Journal of Medicinal Chemistry, 223:113735, 2021 : PubMed